Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies.

Meyer S, Evers M, Jansen JHM, Buijs J, Broek B, Reitsma SE, Moerer P, Amini M, Kretschmer A, Ten Broeke T, den Hartog MT, Rijke M, Klein C, Valerius T, Boross P, Leusen JHW.

Br J Haematol. 2018 Mar;180(6):808-820. doi: 10.1111/bjh.15132. Epub 2018 Feb 22.

PMID:
29468712
2.

Mesenchymal stem cell therapy in proteoglycan induced arthritis.

Swart JF, de Roock S, Hofhuis FM, Rozemuller H, van den Broek T, Moerer P, Broere F, van Wijk F, Kuis W, Prakken BJ, Martens AC, Wulffraat NM.

Ann Rheum Dis. 2015 Apr;74(4):769-77. doi: 10.1136/annrheumdis-2013-204147. Epub 2014 Jan 6.

PMID:
24395558
3.

Reconstructing the human hematopoietic niche in immunodeficient mice: opportunities for studying primary multiple myeloma.

Groen RW, Noort WA, Raymakers RA, Prins HJ, Aalders L, Hofhuis FM, Moerer P, van Velzen JF, Bloem AC, van Kessel B, Rozemuller H, van Binsbergen E, Buijs A, Yuan H, de Bruijn JD, de Weers M, Parren PW, Schuringa JJ, Lokhorst HM, Mutis T, Martens AC.

Blood. 2012 Jul 19;120(3):e9-e16. doi: 10.1182/blood-2012-03-414920. Epub 2012 May 31.

PMID:
22653974
4.

Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids.

Roodhart JM, Daenen LG, Stigter EC, Prins HJ, Gerrits J, Houthuijzen JM, Gerritsen MG, Schipper HS, Backer MJ, van Amersfoort M, Vermaat JS, Moerer P, Ishihara K, Kalkhoven E, Beijnen JH, Derksen PW, Medema RH, Martens AC, Brenkman AB, Voest EE.

Cancer Cell. 2011 Sep 13;20(3):370-83. doi: 10.1016/j.ccr.2011.08.010.

5.

HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20 low expressing tumor cells that resist rituximab-mediated lysis.

van Meerten T, Rozemuller H, Hol S, Moerer P, Zwart M, Hagenbeek A, Mackus WJ, Parren PW, van de Winkel JG, Ebeling SB, Martens AC.

Haematologica. 2010 Dec;95(12):2063-71. doi: 10.3324/haematol.2010.025783. Epub 2010 Sep 17.

6.

The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.

van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H.

Cell. 2002 Oct 18;111(2):241-50.

7.

Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription.

Staal FJ, Meeldijk J, Moerer P, Jay P, van de Weerdt BC, Vainio S, Nolan GP, Clevers H.

Eur J Immunol. 2001 Jan;31(1):285-93.

8.

Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1.

Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, Logtenberg T, Clevers H.

Science. 1999 Sep 17;285(5435):1923-6.

9.

Uncoupling of S phase and mitosis in cardiomyocytes and hepatocytes lacking the winged-helix transcription factor Trident.

Korver W, Schilham MW, Moerer P, van den Hoff MJ, Dam K, Lamers WH, Medema RH, Clevers H.

Curr Biol. 1998 Dec 3;8(24):1327-30.

10.

The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors.

Roose J, Molenaar M, Peterson J, Hurenkamp J, Brantjes H, Moerer P, van de Wetering M, Destrée O, Clevers H.

Nature. 1998 Oct 8;395(6702):608-12.

PMID:
9783587
11.

Critical involvement of Tcf-1 in expansion of thymocytes.

Schilham MW, Wilson A, Moerer P, Benaissa-Trouw BJ, Cumano A, Clevers HC.

J Immunol. 1998 Oct 15;161(8):3984-91.

12.

Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4.

Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, Clevers H.

Nat Genet. 1998 Aug;19(4):379-83.

PMID:
9697701
13.

Sox-4 facilitates thymocyte differentiation.

Schilham MW, Moerer P, Cumano A, Clevers HC.

Eur J Immunol. 1997 May;27(5):1292-5.

PMID:
9174623
14.

Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4.

Schilham MW, Oosterwegel MA, Moerer P, Ya J, de Boer PA, van de Wetering M, Verbeek S, Lamers WH, Kruisbeek AM, Cumano A, Clevers H.

Nature. 1996 Apr 25;380(6576):711-4.

PMID:
8614465
15.

Isolation and characterization of the rat gene encoding glutamate dehydrogenase.

Das AT, Arnberg AC, Malingré H, Moerer P, Charles R, Moorman AF, Lamers WH.

Eur J Biochem. 1993 Feb 1;211(3):795-803.

16.

Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy.

Wijmenga C, Hewitt JE, Sandkuijl LA, Clark LN, Wright TJ, Dauwerse HG, Gruter AM, Hofker MH, Moerer P, Williamson R, et al.

Nat Genet. 1992 Sep;2(1):26-30.

PMID:
1363881
17.

Genetic linkage map of facioscapulohumeral muscular dystrophy and five polymorphic loci on chromosome 4q35-qter.

Wijmenga C, Sandkuijl LA, Moerer P, van der Boorn N, Bodrug SE, Ray PN, Brouwer OF, Murray JC, van Ommen GJ, Padberg GW, et al.

Am J Hum Genet. 1992 Aug;51(2):411-5.

18.

Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization.

Wijmenga C, Padberg GW, Moerer P, Wiegant J, Liem L, Brouwer OF, Milner EC, Weber JL, van Ommen GB, Sandkuyl LA, et al.

Genomics. 1991 Apr;9(4):570-5.

PMID:
2037288
19.

Location of facioscapulohumeral muscular dystrophy gene on chromosome 4.

Wijmenga C, Frants RR, Brouwer OF, Moerer P, Weber JL, Padberg GW.

Lancet. 1990 Sep 15;336(8716):651-3.

PMID:
1975852
20.

Nucleotide sequence of rat liver glutamate dehydrogenase cDNA.

Das AT, Moerer P, Charles R, Moorman AF, Lamers WH.

Nucleic Acids Res. 1989 Mar 25;17(6):2355. No abstract available.

Supplemental Content

Loading ...
Support Center